ARL8A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.822000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.398400E-01
Normal-vs-Stage2
5.073400E-01
Normal-vs-Stage3
7.982000E-01
Normal-vs-Stage4
1.927040E-01
Stage1-vs-Stage2
7.225600E-01
Stage1-vs-Stage3
9.385000E-01
Stage1-vs-Stage4
5.199600E-01
Stage2-vs-Stage3
9.413200E-01
Stage2-vs-Stage4
6.348600E-01
Stage3-vs-Stage4
7.657600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.602800E-01
Normal-vs-AfricanAmerican
1.128230E-01
Normal-vs-Asian
1.166390E-01
Caucasian-vs-AfricanAmerican
2.000400E-01
Caucasian-vs-Asian
7.549700E-02
AfricanAmerican-vs-Asian
9.570000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.891800E-01
Normal-vs-Female
4.984200E-01
Male-vs-Female
8.624000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.851600E-01
Normal-vs-Age(41-60Yrs)
1.695190E-01
Normal-vs-Age(61-80Yrs)
6.124000E-01
Normal-vs-Age(81-100Yrs)
6.566200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.295800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.350600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.818800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.291640E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.995810E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.182200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.246800E-01
Normal-vs-Daily Drinker
5.981000E-01
Normal-vs-Weekly Drinker
2.605000E-01
Normal-vs-Occasional Drinker
2.594000E-01
Normal-vs-Social Drinker
4.954200E-01
Non Drinker-vs-Daily Drinker
6.832000E-01
Non Drinker-vs-Weekly Drinker
3.540800E-01
Non Drinker-vs-Occasional Drinker
5.494600E-01
Non Drinker-vs-Social Drinker
7.107600E-01
Daily Drinker-vs-Weekly Drinker
1.884600E-01
Daily Drinker-vs-Occasional Drinker
2.954200E-01
Daily Drinker-vs-Social Drinker
9.917800E-01
Weekly Drinker-vs-Occasional Drinker
6.647200E-01
Weekly Drinker-vs-Social Drinker
1.863210E-01
Occasional Drinker-vs-Social Drinker
2.837600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.786000E-02
Normal-vs-Grade 2
1.142350E-03
Normal-vs-Grade 3
1.125530E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.263980E-01
Grade 1-vs-Grade 3
2.333000E-01
Grade 1-vs-Grade 4
3.786000E-02
Grade 2-vs-Grade 3
9.561400E-01
Grade 2-vs-Grade 4
1.142350E-03
Grade 3-vs-Grade 4
1.125530E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.462600E-01
Normal-vs-NonDiabetic
2.951800E-01
Diabetic-vs-NonDiabetic
5.059700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.466200E-02
Normal-vs-NoPancreatitis
4.811600E-01
Pancreatitis-vs-NoPancreatitis
9.638100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.852200E-01
Normal-vs-N1
5.520000E-01
N0-vs-N1
2.922800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.095600E-01
Normal-vs-TP53-NonMutant
9.953200E-01
TP53-Mutant-vs-TP53-NonMutant
1.306370E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
